SCHEMBL5583140

SCHEMBL5583140

Cc1ccc2[nH]c3c(c2c1)CCc1cn[nH]c1-3

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 18/20 1.00
KDM4E B2RXH2 5/20 1.00
ALDH1A1 P00352 5/20 1.00
LMNA P02545 4/20 1.00
HSD17B10 Q99714 4/20 1.00
MEN1 O00255 4/20 1.00
MAPT P10636 4/20 1.00
KMT2A Q03164 4/20 1.00
MAPK1 P28482 2/20 1.00
TSHR P16473 2/20 1.00
RAB9A P51151 2/20 1.00
NPC1 O15118 1/20 1.00
MPI P34949 1/20 1.00
RIPK1 Q13546 16/20 0.71
USP2 O75604 1/20 0.71
HSP90AA1 P07900 1/20 0.71
ALOX15 P16050 1/20 0.71
GFER P55789 1/20 0.71
HPGD P15428 2/20 0.68
AURKA O14965 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071355 0.83 MAPK10 (0.71) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL5583258 0.83 MAPK10 (0.71) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL5582980 0.83 MAPK10 (1.00) MAPK10KDM4EALDH1A1LMNAHSD17B10
Hydrochloric Acid SCHEMBL6071243 0.82 MAPK10 (0.70) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL5583162 0.81 MAPK10 (1.00) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL30489859 0.81 MAPK10 (1.00) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL6071229 0.79 MAPK10 (0.65) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL6071613 0.78 MAPK10 (0.64) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL6071308 0.78 MAPK10 (0.63) MAPK10KDM4EALDH1A1LMNAHSD17B10
SCHEMBL6070746 0.78 MAPK10 (0.63) MAPK10KDM4EALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US claimed
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer IGF1R, KDR, ERBB2 MAPK10 1222/4885KDM4E 1419/4885ALDH1A1 1181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.